Loading...

Allied Healthcare Products

Nasdaq:AHPI
Snowflake Description

Excellent balance sheet and slightly overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
AHPI
Nasdaq
$7M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The last earnings update was 66 days ago. More info.


Add to Portfolio Compare Print
AHPI Share Price and Events
7 Day Returns
-10.4%
NasdaqCM:AHPI
1.1%
US Medical Equipment
-1.2%
US Market
1 Year Returns
-34.4%
NasdaqCM:AHPI
15.1%
US Medical Equipment
3.4%
US Market
AHPI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Allied Healthcare Products (AHPI) -10.4% -10.1% -8.4% -34.4% 36.7% -61.9%
US Medical Equipment 1.1% 1.4% 13.5% 15.1% 63.6% 103.7%
US Market -1.2% 1.2% 1.7% 3.4% 35.5% 41.6%
1 Year Return vs Industry and Market
  • AHPI underperformed the Medical Equipment industry which returned 15.1% over the past year.
  • AHPI underperformed the Market in United States of America which returned 3.4% over the past year.
Price Volatility
AHPI
Industry
5yr Volatility vs Market

AHPI Value

 Is Allied Healthcare Products undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Allied Healthcare Products to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Allied Healthcare Products.

NasdaqCM:AHPI Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 8.3%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqCM:AHPI
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Medical Equipment Unlevered Beta Simply Wall St/ S&P Global 0.87
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.87 (1 + (1- 21%) (6.24%))
0.941
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.94
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.941 * 5.96%)
8.34%

Discounted Cash Flow Calculation for NasdaqCM:AHPI using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Allied Healthcare Products is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NasdaqCM:AHPI DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 8.34%)
2020 0.21 Est @ 49.43% 0.19
2021 0.29 Est @ 35.42% 0.24
2022 0.36 Est @ 25.61% 0.28
2023 0.43 Est @ 18.75% 0.31
2024 0.49 Est @ 13.94% 0.33
2025 0.54 Est @ 10.58% 0.33
2026 0.58 Est @ 8.22% 0.33
2027 0.62 Est @ 6.58% 0.33
2028 0.65 Est @ 5.42% 0.32
2029 0.68 Est @ 4.61% 0.31
Present value of next 10 years cash flows $2.97
NasdaqCM:AHPI DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $0.68 × (1 + 2.73%) ÷ (8.34% – 2.73%)
$12.51
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $12.51 ÷ (1 + 8.34%)10
$5.61
NasdaqCM:AHPI Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $2.97 + $5.61
$8.58
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $8.58 / 4.01
$2.14
NasdaqCM:AHPI Discount to Share Price
Calculation Result
Value per share (USD) From above. $2.14
Current discount Discount to share price of $1.64
= -1 x ($1.64 - $2.14) / $2.14
23.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Allied Healthcare Products is available for.
Intrinsic value
23%
Share price is $1.64 vs Future cash flow value of $2.14
Current Discount Checks
For Allied Healthcare Products to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Allied Healthcare Products's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Allied Healthcare Products's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Allied Healthcare Products's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Allied Healthcare Products's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:AHPI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $-0.44
NasdaqCM:AHPI Share Price ** NasdaqCM (2019-07-19) in USD $1.64
United States of America Medical Equipment Industry PE Ratio Median Figure of 63 Publicly-Listed Medical Equipment Companies 40.94x
United States of America Market PE Ratio Median Figure of 3,080 Publicly-Listed Companies 17.88x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Allied Healthcare Products.

NasdaqCM:AHPI PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:AHPI Share Price ÷ EPS (both in USD)

= 1.64 ÷ -0.44

-3.7x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allied Healthcare Products is loss making, we can't compare its value to the US Medical Equipment industry average.
  • Allied Healthcare Products is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Allied Healthcare Products's expected growth come at a high price?
Raw Data
NasdaqCM:AHPI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -3.7x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Medical Equipment Industry PEG Ratio Median Figure of 54 Publicly-Listed Medical Equipment Companies 2.38x
United States of America Market PEG Ratio Median Figure of 2,119 Publicly-Listed Companies 1.57x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Allied Healthcare Products, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Allied Healthcare Products's assets?
Raw Data
NasdaqCM:AHPI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $3.08
NasdaqCM:AHPI Share Price * NasdaqCM (2019-07-19) in USD $1.64
United States of America Medical Equipment Industry PB Ratio Median Figure of 182 Publicly-Listed Medical Equipment Companies 4.37x
United States of America Market PB Ratio Median Figure of 5,245 Publicly-Listed Companies 1.79x
NasdaqCM:AHPI PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:AHPI Share Price ÷ Book Value per Share (both in USD)

= 1.64 ÷ 3.08

0.53x

* Primary Listing of Allied Healthcare Products.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Allied Healthcare Products is good value based on assets compared to the US Medical Equipment industry average.
X
Value checks
We assess Allied Healthcare Products's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Allied Healthcare Products has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

AHPI Future Performance

 How is Allied Healthcare Products expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allied Healthcare Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
21.4%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Allied Healthcare Products expected to grow at an attractive rate?
  • Unable to compare Allied Healthcare Products's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Allied Healthcare Products's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Allied Healthcare Products's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:AHPI Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.4%
United States of America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 7.8%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.9%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:AHPI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:AHPI Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 32 0 -2
2018-12-31 33 -1 -3
2018-09-30 33 -1 -3
2018-06-30 34 -1 -2
2018-03-31 33 -1 -3
2017-12-31 33 -1 -2
2017-09-30 33 -1 -2
2017-06-30 34 -1 -2
2017-03-31 35 -1 -2
2016-12-31 35 -1 -2
2016-09-30 36 -1 -3
2016-06-30 36 0 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Allied Healthcare Products is high growth as no earnings estimate data is available.
  • Unable to determine if Allied Healthcare Products is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:AHPI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Allied Healthcare Products Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:AHPI Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 -0.44
2018-12-31 -0.76
2018-09-30 -0.66
2018-06-30 -0.55
2018-03-31 -0.63
2017-12-31 -0.51
2017-09-30 -0.51
2017-06-30 -0.52
2017-03-31 -0.47
2016-12-31 -0.56
2016-09-30 -0.65
2016-06-30 -0.57

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Allied Healthcare Products will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine Allied Healthcare Products's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. Allied Healthcare Products's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Allied Healthcare Products's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Allied Healthcare Products's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Allied Healthcare Products has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

AHPI Past Performance

  How has Allied Healthcare Products performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Allied Healthcare Products's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Allied Healthcare Products does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Allied Healthcare Products's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Allied Healthcare Products's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Allied Healthcare Products's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Allied Healthcare Products Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:AHPI Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 32.37 -1.78 7.55 0.47
2018-12-31 32.52 -3.06 7.77 0.47
2018-09-30 33.13 -2.66 7.95 0.47
2018-06-30 33.76 -2.19 7.97 0.47
2018-03-31 33.30 -2.54 8.01 0.41
2017-12-31 33.42 -2.05 8.03 0.41
2017-09-30 32.97 -2.04 7.95 0.41
2017-06-30 33.51 -2.09 8.20 0.41
2017-03-31 34.94 -1.88 8.21 0.46
2016-12-31 35.19 -2.26 8.46 0.46
2016-09-30 35.77 -2.59 8.86 0.46
2016-06-30 35.79 -2.30 8.82 0.46
2016-03-31 34.96 -2.54 8.77 0.53
2015-12-31 34.63 -2.26 8.57 0.53
2015-09-30 34.78 -1.60 8.30 0.53
2015-06-30 35.16 -1.78 8.24 0.53
2015-03-31 35.85 -1.60 8.25 0.66
2014-12-31 36.47 -2.07 8.77 0.66
2014-09-30 36.22 -2.92 9.42 0.66
2014-06-30 36.08 -2.81 9.77 0.66
2014-03-31 36.71 -2.56 9.83 0.94
2013-12-31 36.80 -1.87 9.76 0.94
2013-09-30 37.97 -1.44 9.78 0.94
2013-06-30 38.55 -1.26 9.80 0.94
2013-03-31 39.09 -1.32 9.71 0.95
2012-12-31 40.58 -1.18 9.63 0.95
2012-09-30 41.34 -0.69 9.47 0.95

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Allied Healthcare Products has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Allied Healthcare Products has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Allied Healthcare Products improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Allied Healthcare Products's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Allied Healthcare Products has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

AHPI Health

 How is Allied Healthcare Products's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Allied Healthcare Products's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Allied Healthcare Products is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Allied Healthcare Products has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Allied Healthcare Products's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 28.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Allied Healthcare Products Company Filings, last reported 3 months ago.

NasdaqCM:AHPI Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 12.36 0.41 0.14
2018-12-31 11.98 1.36 0.33
2018-09-30 12.76 0.38 0.00
2018-06-30 14.00 0.00 0.14
2018-03-31 14.14 0.68 0.27
2017-12-31 15.04 0.00 0.00
2017-09-30 15.42 0.00 0.24
2017-06-30 16.19 0.00 1.00
2017-03-31 16.68 0.00 0.80
2016-12-31 17.08 0.00 0.85
2016-09-30 17.46 0.00 1.36
2016-06-30 18.27 0.00 1.70
2016-03-31 18.55 0.00 1.73
2015-12-31 19.34 0.00 1.64
2015-09-30 20.05 0.00 2.00
2015-06-30 20.69 0.00 2.04
2015-03-31 21.22 0.00 1.83
2014-12-31 21.73 0.00 1.54
2014-09-30 21.80 0.00 1.72
2014-06-30 22.51 0.00 1.37
2014-03-31 22.86 0.00 1.53
2013-12-31 23.83 0.00 2.28
2013-09-30 24.73 0.00 3.08
2013-06-30 25.31 0.00 3.69
2013-03-31 25.40 0.00 4.33
2012-12-31 25.68 0.00 4.59
2012-09-30 26.38 0.00 5.39
  • Allied Healthcare Products's level of debt (3.3%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (0% vs 3.3% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Allied Healthcare Products has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Allied Healthcare Products has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 8.9% per year.
X
Financial health checks
We assess Allied Healthcare Products's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Allied Healthcare Products has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

AHPI Dividends

 What is Allied Healthcare Products's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Allied Healthcare Products dividends.
If you bought $2,000 of Allied Healthcare Products shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Allied Healthcare Products's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Allied Healthcare Products's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:AHPI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 24 Stocks 1.2%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2016 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Allied Healthcare Products has not reported any payouts.
  • Unable to verify if Allied Healthcare Products's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Allied Healthcare Products's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Allied Healthcare Products has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Allied Healthcare Products's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Allied Healthcare Products afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Allied Healthcare Products has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

AHPI Management

 What is the CEO of Allied Healthcare Products's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Earl Refsland
COMPENSATION $502,741
AGE 76
TENURE AS CEO 19.8 years
CEO Bio

Mr. Earl R. Refsland has been the President and Chief Executive Officer at Allied Healthcare Products Inc. since September 1999. From May 1995 to March 1998, Mr. Refsland served as the President and Chief Executive Officer of Photometrics Limited. He served as the Chief Executive Officer of Allied Healthcare Products, Inc. from 1986 to 1993.From February 1999 to January 2000, Mr. Refsland served as the Chairman of the Board at Andros Technologies. Mr. Refsland has been a Director of Allied Healthcare Products Inc. since September 1999. He served as Director of Allied Healthcare Products, Inc. from 1986 to 1993.

CEO Compensation
  • Earl's compensation has increased whilst company is loss making.
  • Earl's remuneration is about average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Allied Healthcare Products management team in years:

18
Average Tenure
60
Average Age
  • The average tenure for the Allied Healthcare Products management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Earl Refsland

TITLE
CEO, President & Director
COMPENSATION
$503K
AGE
76
TENURE
19.8 yrs

Daniel Dunn

TITLE
VP of Finance
COMPENSATION
$248K
AGE
60
TENURE
18 yrs

Andrew Riley

TITLE
Vice President of Operations
COMPENSATION
$225K
AGE
43
TENURE
5 yrs
Board of Directors Tenure

Average tenure and age of the Allied Healthcare Products board of directors in years:

15.4
Average Tenure
75
Average Age
  • The average tenure for the Allied Healthcare Products board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

John Weil

TITLE
Chairman
COMPENSATION
$25K
AGE
78

Earl Refsland

TITLE
CEO, President & Director
COMPENSATION
$503K
AGE
76
TENURE
19.8 yrs

Judy Graves

TITLE
Director
COMPENSATION
$27K
AGE
72
TENURE
15.4 yrs

Joseph Root

TITLE
Director
COMPENSATION
$26K
AGE
74
TENURE
12.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Allied Healthcare Products's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Allied Healthcare Products has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

AHPI News

Simply Wall St News

Those Who Purchased Allied Healthcare Products (NASDAQ:AHPI) Shares Five Years Ago Have A 61% Loss To Show For It

View our latest analysis for Allied Healthcare Products Because Allied Healthcare Products is loss-making, we think the market is probably more focussed on revenue and revenue growth, at least for now. … In the last five years Allied Healthcare Products saw its revenue shrink by 2.3% per year. … A Different Perspective Investors in Allied Healthcare Products had a tough year, with a total loss of 37%, against a market gain of about 7.0%.

Simply Wall St -

Is Allied Healthcare Products, Inc.'s (NASDAQ:AHPI) CEO Overpaid Relative To Its Peers?

Check out our latest analysis for Allied Healthcare Products How Does Earl Refsland's Compensation Compare With Similar Sized Companies? … I think that the total shareholder return of 73%, over three years, would leave most Allied Healthcare Products, Inc. … If you want to buy a stock that is better than Allied Healthcare Products, this free list of high return, low debt companies is a great place to look.

Simply Wall St -

Calculating The Intrinsic Value Of Allied Healthcare Products, Inc. (NASDAQ:AHPI)

Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate: 10-year free cash flow (FCF) forecast 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 Levered FCF ($, Millions) $0.21 $0.29 $0.36 $0.43 $0.49 $0.54 $0.58 $0.62 $0.65 $0.68 Growth Rate Estimate Source Est @ 49.43% Est @ 35.42% Est @ 25.61% Est @ 18.75% Est @ 13.94% Est @ 10.58% Est @ 8.22% Est @ 6.58% Est @ 5.42% Est @ 4.61% Present Value ($, Millions) Discounted @ 8.44% $0.19 $0.24 $0.28 $0.31 $0.32 $0.33 $0.33 $0.32 $0.31 $0.30 Present Value of 10-year Cash Flow (PVCF)= $2.95m "Est" = FCF growth rate estimated by Simply Wall St We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. … Terminal Value (TV) = FCF2029 × (1 + g) ÷ (r – g) = US$683k × (1 + 2.7%) ÷ (8.4% – 2.7%) = US$12m Present Value of Terminal Value (PVTV) = TV / (1 + r)10 = $US$12m ÷ ( 1 + 8.4%)10 = $5.46m The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is $8.42m. … NasdaqCM:AHPI Intrinsic value, May 23rd 2019 The assumptions We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows.

Simply Wall St -

How Much Of Allied Healthcare Products, Inc. (NASDAQ:AHPI) Do Insiders Own?

A look at the shareholders of Allied Healthcare Products, Inc. … With a market capitalization of US$7.0m, Allied Healthcare Products is a small cap stock, so it might not be well known by many institutional investors. … View our latest analysis for Allied Healthcare Products

Simply Wall St -

Allied Healthcare Products, Inc. (NASDAQ:AHPI): Time For A Financial Health Check

Help shape the future of investing tools and receive a $20 prize! … While small-cap stocks, such as Allied Healthcare Products, Inc. … (NASDAQ:AHPI) with its market cap of US$7.6m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn.

Simply Wall St -

What Kind Of Shareholders Own Allied Healthcare Products Inc (NASDAQ:AHPI)?

If you want to know who really controls Allied Healthcare Products Inc (NASDAQ:AHPI), then you'll have to look at the makeup of its share registry. … Allied Healthcare Products is not a large company by global standards. … View our latest analysis for Allied Healthcare Products

Simply Wall St -

Does Allied Healthcare Products Inc's (NASDAQ:AHPI) CEO Salary Compare Well With Others?

Leading Allied Healthcare Products Inc (NASDAQ:AHPI) as the CEO, Earl Refsland took the company to a valuation of US$10.06m. … Understanding how CEOs are incentivised to run and grow their company is an important aspect of investing in a stock. … CEOs leading companies of similar size and profitability

Simply Wall St -

Allied Healthcare Products Inc (NASDAQ:AHPI): Does The Earnings Decline Make It An Underperformer?

Today I will take a look at Allied Healthcare Products Inc's (NASDAQ:AHPI) most recent earnings update (31 March 2018) and compare these latest figures against its performance over the past few years, as well as how the rest of the medical equipment industry performed. … Check out our latest analysis for Allied Healthcare Products? … AHPI is loss-making, with the most recent trailing twelve-month earnings of -US$2.54m (from 31 March 2018), which compared to last year has become

Simply Wall St -

What Did Allied Healthcare Products Inc's (NASDAQ:AHPI) CEO Take Home Last Year?

See our latest analysis for Allied Healthcare Products What has AHPI's performance been like? … Typically I would use earnings and market cap to account for variations in performance, however, AHPI's negative earnings reduces the effectiveness of this method. … Putting everything together, though AHPI is loss-making, it seems like the CEO’s pay is fair.

Simply Wall St -

Why Allied Healthcare Products Inc's (NASDAQ:AHPI) Ownership Structure Is Important

I am going to take a deep dive into Allied Healthcare Products Inc’s (NASDAQ:AHPI) most recent ownership structure, not a frequent subject of discussion among individual investors. … Check out our latest analysis for Allied Healthcare Products NasdaqCM:AHPI Ownership_summary May 17th 18 Institutional Ownership In AHPI's case, institutional ownership stands at 11.99%, significant enough to cause considerable price moves in the case of large institutional transactions, especially when there is a low level of public shares available on the market to trade. … Next Steps: AHPI's considerably high level of institutional ownership calls for further analysis into its margin of safety.

Simply Wall St -

AHPI Company Info

Description

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company’s respiratory care/anesthesia products comprise air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing products, facemasks, cannulas, and ventilator circuits; and home respiratory care products include aluminum oxygen cylinders, oxygen regulators, pneumatic nebulizers, and portable suction equipment. It also provides medical gas equipment, which comprise construction products consisting of in-wall medical system components, central station pumps and compressors, and headwalls; regulation devices and suction equipment comprising flowmeters, vacuum regulators, and pressure regulators, as well as related adapters, fittings, and hoses that measure, regulate, monitor, and transfer medical gases from walled piping or equipment to patients; and disposable oxygen cylinders to provide oxygen for short periods. In addition, the company offers medical products that include respiratory/resuscitation products comprising demand resuscitation valves, portable resuscitation systems, bag masks and related products, emergency transport ventilators, precision oxygen regulators, minilators, multilators, and humidifiers; and trauma and patient handling products, such as spine immobilization products, pneumatic anti-shock garments, and trauma burn kits. It serves hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, emergency medical products dealers, and others. Allied Healthcare Products, Inc. was founded in 1979 and is headquartered in St. Louis, Missouri.

Details
Name: Allied Healthcare Products, Inc.
AHPI
Exchange: NasdaqCM
Founded: 1979
$6,582,200
4,013,537
Website: http://www.alliedhpi.com
Address: Allied Healthcare Products, Inc.
1720 Sublette Avenue,
St. Louis,
Missouri, 63110,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM AHPI Common Stock Nasdaq Capital Market US USD 15. Jan 1992
Number of employees
Current staff
Staff numbers
202
Allied Healthcare Products employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/20 23:31
End of day share price update: 2019/07/19 00:00
Last earnings filing: 2019/05/15
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.